Saudi Basic Industries Q2 Profits Fall 35%

Saudi Basic Industries Corp (SABIC), the world's biggest petrochemicals group by market value, reported a 35% drop in quarterly profits on Wednesday due to lower prices and production, missing analysts' estimates.

SABIC, which is 70% state-owned, said second quarter net profit was 5.3 billion riyals ($1.41 billion) for the quarter ended June 30, down from 8.1 billion riyals in the prior-year period.

Analysts had forecast, on average, profit of 6.58 billion riyals, in a Reuters poll.

It declared a 2-riyals per share dividend on Wednesday, for the first half of 2012.

The bellwether Middle East conglomerate, which supplies chemicals, industrial polymers, fertilisers and metals globally, blamed the lower profits on a combination of weaker product pricing, the impact of plant maintenance on production and sales volumes as well as higher raw materials costs.

SABIC's profits had fallen in the two previous quarters amid slipping demand in China. But record earnings in the second and third quarter of 2011 helped it achieve a bumper year.

The conglomerate's products are used in a wide variety of industries, from car manufacture to house construction and cheap retail goods making it highly sensitive to movements in the global economy.

SABIC enjoys a comparative advantage over some other chemical producers because much of its feedstock comes from subsidised natural gas supplied by the government.

SABIC said in June it was repaying an 8 billion-riyal Islamic bond, or sukuk, ahead of time.

 

 

 

 

 

 

 

 

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.